- Meta-analysis found no statistically significant difference between red and white wine consumption in relation to overall cancer risk.
- Resveratrol's anticarcinogenic properties did not appear to translate to reduced cancer risk among red wine drinkers in real-world observational studies.
- Subgroup analyses revealed notable differences, especially in women and in cohort studies.
- White wine consumption was associated with a significantly higher cancer risk than red wine.
- The study challenges the common belief that red wine is healthier than white wine.
- Research addressed a significant gap in understanding alcohol's relationship to cancer.
- Further research on white wine's association with increased cancer risk, particularly skin cancer, is suggested.
- The meta-analysis included cancers of various sites, including lymphoma, skin, prostate, breast, colorectal, ovarian, lung, renal/urinary tract, pancreatic, brain, gastric, and oral/pharyngeal cancers.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
